| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 09/10/2009 | US20090227592 Compounds effecting glucokinase |
| 09/10/2009 | US20090227583 2-aminoquinolines |
| 09/10/2009 | US20090227571 Androgen Receptor Modulator Compounds and Methods |
| 09/10/2009 | US20090227570 2-aminoquinolines |
| 09/10/2009 | US20090227569 Pyrrolidine derivatives |
| 09/09/2009 | EP2098517A1 Novel phenyl-isoxazol-3-ol derivative |
| 09/09/2009 | EP2098508A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/09/2009 | EP2097405A2 Anti-viral compounds |
| 09/09/2009 | EP2097373A1 Sulfonamide derivatives as liver carnitine palmitoyl transferase (l-cptl ) |
| 09/09/2009 | EP1902050B1 Oxazolidinone derivatives and use thereof as antibiotics |
| 09/09/2009 | EP1638963B1 N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors |
| 09/09/2009 | EP1379243B1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 09/09/2009 | EP0999835B1 Imidazole derivatives as mdr modulators |
| 09/09/2009 | CN101528739A N- (2 -hydroxyethyl) -n-methyl- 4- (quinolin- 8-yl (1- (thiazol-4- ylmethyl) piperidin- 4 -ylidene) methyl) benzamide, the process of making it as well as its use for the treatment of pain, anxiety an |
| 09/09/2009 | CN101528738A 5-(2-furyl)-1,3-thiazole derivatives useful as inhibitors of phosphatidylinositol 3-kinase |
| 09/09/2009 | CN100537551C Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents |
| 09/09/2009 | CN100536841C Cyclopropyl and cyclobutyl epothilone analogs |
| 09/08/2009 | US7585975 A group is bonded to at least one of the carbons at the 5, 6, 7 or 8 position of the bicyclic ring, and the ring is substituted by up to three independent R3 groups. The invention also includes methods of using these compounds as type I receptor tyrosine kinase inhibitors and hyperproliferation diseases |
| 09/08/2009 | US7585888 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 09/08/2009 | US7585880 Phenylpropanoic acid derivatives |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | US7585860 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/08/2009 | US7585853 Compounds having selective inhibiting effect at GSK3 |
| 09/08/2009 | CA2387351C Indole derivatives as tyrosine kinase inhibitors |
| 09/08/2009 | CA2342739C Azetidine derivatives, preparation and medicines containing them |
| 09/08/2009 | CA2223678C Covalently linked oligonucleotide minor groove binder conjugates |
| 09/08/2009 | CA2213466C Inhibitors of microsomal triglyceride transfer protein and method |
| 09/08/2009 | CA2141731C Antifungal agents, processes for the preparation thereof, and intermediates |
| 09/03/2009 | WO2009107764A1 Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens |
| 09/03/2009 | WO2009107391A1 Compound having 6-membered aromatic ring |
| 09/03/2009 | WO2009107387A1 2-oxochromene derivative |
| 09/03/2009 | WO2009106982A1 Indazole derivatives |
| 09/03/2009 | WO2009106885A1 Heterocyclic urea derivatives and methods of use thereof-211 |
| 09/03/2009 | WO2009106586A1 Quinolines as inhibitors of farnesyl pyrophosphate synthase |
| 09/03/2009 | WO2009106203A1 Glucokinase activators |
| 09/03/2009 | WO2009105969A1 Epothilone analogues, their pharmaceutical compositions, their use and their preparations |
| 09/03/2009 | WO2009105824A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
| 09/03/2009 | WO2009068170A3 2-(benzyl- and 1h-pyrazol-4-ylmethyl)sulfinyl thiazole derivatives as herbicides and plant growth regulators |
| 09/03/2009 | WO2008131860A3 Pyridonecarboxamides crop protection agents containing the same method for production and use thereof |
| 09/03/2009 | US20090221824 Enantioselective process |
| 09/03/2009 | US20090221647 N-(2-thiazolyl)-amide derivatives as gsk-3 inhibitors |
| 09/03/2009 | US20090221635 Quinolinyl and benzothiazolyl modulators |
| 09/03/2009 | US20090221616 Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors |
| 09/03/2009 | US20090221604 Thiazole Compounds and Their Use as PGD2 Antagonists |
| 09/03/2009 | US20090221587 Novel insecticides |
| 09/03/2009 | US20090221564 Heterocyclic Compounds and Their Use in the Treatment of Cardiovascular Disease |
| 09/03/2009 | US20090221547 Immunosuppressant Compounds and Compositions |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/03/2009 | US20090218039 Coloring composition, thermal transfer recording ink sheet, thermal transfer recording method, color toner, inkjet ink, color filter, and dye compound |
| 09/03/2009 | CA2717011A1 Quinolines as inhibitors of farnesyl pyrophosphate synthase |
| 09/03/2009 | CA2716898A1 Compound having 6-membered aromatic ring |
| 09/03/2009 | CA2716647A1 Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens |
| 09/03/2009 | CA2716599A1 Glucokinase activators |
| 09/03/2009 | CA2716396A1 Novel compositions for treatment of diseases related to activated lymphocytes |
| 09/03/2009 | CA2716365A1 Heterocyclic urea derivatives and methods of use thereof-211 |
| 09/03/2009 | CA2716316A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
| 09/03/2009 | CA2714573A1 Indazole derivatives |
| 09/02/2009 | EP2096112A2 Thiazoline acid derivatives |
| 09/02/2009 | EP2094692A2 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof |
| 09/02/2009 | EP2094690A2 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists |
| 09/02/2009 | EP2094685A2 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperdine derivatives as orexin receptor inhibitors |
| 09/02/2009 | EP2094670A1 Heterocyclyc sulfonamides having edg-i antagonistic activity |
| 09/02/2009 | EP2094663A2 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia |
| 09/02/2009 | EP2094659A1 Heteroaryl (substituted) alkyl n-substituted sulfoximines as insecticides |
| 09/02/2009 | EP2094272A2 Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors |
| 09/02/2009 | EP1909792B1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 09/02/2009 | EP1888574B1 New antibiotic derivatives |
| 09/02/2009 | EP1758860B1 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states |
| 09/02/2009 | EP1572215B1 Benzo[d]azepine derivatives for the treatment of neurological disorders |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1300395B1 4-substituted piperidine compound |
| 09/02/2009 | CN101522692A Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate |
| 09/02/2009 | CN101522673A 2-pyridinecarboxamide derivative having gk-activating activity |
| 09/02/2009 | CN101519404A 15-cyclothiaketone derivative, preparation method and application thereof |
| 09/02/2009 | CN101519386A Large conductance calcium-activated K channel opener |
| 09/02/2009 | CN100534988C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 09/01/2009 | US7582770 3-(2-{1-[(3-Cyclopentyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carbonyl)amino]cyclobutyl}-1-methyl-1H-benzoimidazol-5-yl)acrylic acid; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 09/01/2009 | US7582761 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582672 Compounds for the treatment of CRTH2-mediated diseases and conditions |
| 09/01/2009 | US7582665 Heterocyclic sulfur compounds and/or prodrugs administered for prophylaxis of thrombocytopenia, anemia or blood disorders |
| 09/01/2009 | US7582664 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics |
| 09/01/2009 | US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/01/2009 | US7582659 effective against aerobic and anerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci; 1-[5(R)-3-[4-[2-[(1 alpha ,5 alpha ,6 beta )-6-Cyano-3-azabicyclo[3.1.0]hexan-6-yl]pyridin-5-yl]-3-fluorophenyl]-2-oxooxazolidin-5-ylmethyl]-1,2,3-triazole; side effect reduction |
| 09/01/2009 | US7582658 Bicyclic compound |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring |
| 09/01/2009 | US7582648 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 09/01/2009 | US7582647 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582641 Gyrase inhibitors and uses thereof |
| 09/01/2009 | US7582635 Benzoazolylpiperazine compounds inhibition of gluatmate receptors; for treatment of urinary incontinence, ulcers, irritable-bowel syndrome, inflammatory-bowel disease, addictive disorders, Parkinson's disease, parkinsonism, anxiety, epilepsy; kits |
| 09/01/2009 | US7582632 Tri(cyclo) substituted amide compounds |
| 09/01/2009 | US7582631 Paget's disease; muscular disorders; cardiovascular disorders; antiinflamamtory agents; antidiabetic agents; autoimmune disease; leukemia |
| 09/01/2009 | US7582629 2-tert-butyl-4-[(4-morpholin-4-ylphenyl)amino]-5-phenylisothiazol-3(2H)-one 1,1-dioxide; modulation of nuclear hormone receptors Liver X Receptor; cardiovascular diseases: atherosclerosis; antiinflammatory agent; Alzheimer's disease, antidiabetic agent; insulin resistance, metabolic disorders |
| 09/01/2009 | US7582627 3-aminoquinazolin-2,4-dione antibacterial agents |
| 09/01/2009 | US7582626 N-{3-[1-(4-Fluoro-benzyl)-4-hydroxy-2-oxo-2,4a,5,6,7,7a-hexahydro-1H-[1]pyrindin-3-yl]-1,1-dioxo-1,4-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-7-yl}-methanesulfonamide;hepatitis C viral infections; hepatitis C NS5B polymerase inhibitors; enzyme inhibitors; viricides; side-effect reduction |
| 09/01/2009 | US7582589 3-carbonylaminothiophenes and their use as fungicides |
| 09/01/2009 | CA2506491C Novel derivatives of pyrrolidines and thiazolidines, process for preparing them and pharmaceutical compositions containing them |
| 08/27/2009 | WO2009105509A1 Amine and ether compounds which modulate the cb2 receptor |
| 08/27/2009 | WO2009104819A1 Benzodiazepine compound and pharmaceutical composition |